Next Quarterly Earnings
Thursday, December 3, 2026
Expected
MapLight Therapeutics
MapLight Therapeutics is a U.S.-based biotechnology company specializing in the development of innovative CNS therapies. Utilizing state-of-the-art neural circuit mapping platforms, the company purposefully addresses complex neurological and psychiatric disorders through targeted therapeutic approaches.
Frequently asked questions
When did MapLight Therapeutics last report quarterly earnings?
MapLight Therapeutics last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -1.32 USD.
How often has MapLight Therapeutics beaten expectations?
MapLight Therapeutics has beaten analyst EPS estimates in 1 of its last 4 evaluated quarters (beat rate: 25%).
How do I add the MapLight Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
1/4
Quarters above estimates
25%
Beat rate
-12%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
MapLight Therapeutics
Country
🇺🇸
More Financial Information